Sigma-Aldrich announced an agreement with the National Heart, Lung, and Blood Institute and Boston University to develop methods to measure several potential biomarkers of atherosclerotic cardiovascular disease using plasma samples from the Framingham Heart Study.
BrainCells Inc. announced that it has signed an agreement with Proximagen Group to acquire sabcomeline, a clinical-stage muscarinic partial agonist that has potential in the treatment of various psychiatric and neurologic disorders.
Detailed pictures reveal how an experimental antibiotic can kill bacteria that are already resistant to existing treatments. The findings could ultimately help scientists to develop new antibiotics to tackle the bacteria responsible for many infections.
Clinical trials from two international research teams have shown that icatibant, a new drug that blocks the action of an inflammatory protein known as bradykinin, is safe and effective in treating acute attacks of hereditary angioedema.
A newly described metabolic pathway used by malaria-causing parasites may help them survive inside human blood cells. The finding clarifies the picture of parasite metabolism and provides clues to potential weak points in the pathway that might be attacked with drugs.
Researchers are some of the first to prove that a gene linked to a disease trait by genome wide association studies can be clinically relevant and an important determinant of disease risk.
Computer scientists and biochemists at the University of Washington two years ago launched an ambitious project harnessing the brainpower of computer gamers to solve medical problems.
Investigators have identified a new mechanism that controls the number of hematopoietic stem cells – cells that give rise to all blood and immune system cells.
As the medical community searches for better vaccines and ways to deliver them, a University of Rochester scientist believes he has discovered a new approach to boosting the body's response to vaccinations.
Scientists are reporting a possible explanation for the bone loss that may occur following long-term use of a medicine widely used to treat epilepsy, bipolar disorder, and other conditions.
Biologists have taken a major step toward understanding the genes and molecules controlling hematopoietic stem cells, with the discovery of a novel group of molecules that are found in high concentrations within HSCs and appear to regulate their production.
Neurobiologists funded by the Office of Naval Research have discovered a potential cure for degenerative vision diseases leading to terminal blindness.
Affymetrix, Inc. announced that it has released an unparalleled data set based on extensive validation of novel SNPs from the 1000 Genomes Project.
GenomeQuest and SGI announced the immediate availability of the world’s first whole-genome analysis (WGA) services for researchers.